OPX Biotechnologies Inc — Form D
OPX Biotechnologies Inc of BOULDER, CO, a company, filed a Form D exempt-offering notice with the SEC on 2011-07-05. The offering totals $45.0M, of which $36.5M was reported sold. Industry: Other Energy.
Offering
- Filed: 2011-07-05
- Form: D
- Accession: 0001403916-11-000001
- Industry: Other Energy
- Exemptions: 06
- Total offering: $45.0M
- Amount sold: $36.5M
- Remaining: $8.5M
- Investors: 6
- Date of first sale: 2011-06-24
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-162282
Issuer
- Name: OPX Biotechnologies Inc
- CIK: 0001403916
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2007
- Address: 2425 55TH STREET, SUITE 100, BOULDER, CO, 80301
- Phone: (720) 219-5747
Officers, directors & promoters (16)
| Name | Role | Location |
|---|
| Robert W Chess | Director | Boulder, CO |
| Charles W Eggert | Director | Boulder, CO |
| Steve W Foster | Director | Boulder, CO |
| Jonathan W Koch | Director | Boulder, CO |
| William W Lese | Director | Boulder, CO |
| Erik W Straser | Director | Lakewood, CO |
| Charles W Eggert | Executive Officer | Boulder, CO |
| Daniel W Muehl | Executive Officer | Boulder, CO |
| William D Lese | Director | New York, NY |
| Michael D Lynch | Executive Officer | Salisbury, CT |
| Robert R Chess | Director | Boulder, CO |
| Charles R Eggert | Director | Boulder, CO |
| Charles R Eggert | Executive Officer | Boulder, CO |
| Ryan R Gill | Director | Boulder, CO |
| Cory D Steffeck | Director | Denver, CO |
| Erik D Straser | Director | Menlo Park, CA |
Other filings by this issuer (1)
More